October 17, 2024 02:54 PM EDT
FDA+

FDA fi­nal­izes guid­ance on gener­ic drugs, can­cer tri­als and neona­tal drug de­vel­op­ment

Zachary Brennan

Senior Editor

The FDA on Thurs­day put the fin­ish­ing touch­es on three fi­nal guid­ance doc­u­ments fo­cused on re­view­ing drug mas­ter files (DMFs) in ad­vance of gener­ic drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times